16.4 C
Saturday, October 31, 2020

Ineffective antivenoms for snakebites – Frontline

Must read

AFL: A information 22-team second-tier competitors for the jap seaboard will substitute the VFL in 2021

The VFL is formally useless and Carlton will subject it’s first stand-alone reserves aspect for in 19 years in a new-look 22 group...

Kyle Daniels trial: Swim teacher’s contact made 8yo really feel ‘bizarre’

A younger lady has instructed a jury it felt “bizarre” and “actually uncomfortable” when her swim trainer touched her vagina as he corrected...
The Indian Telegraphhttps://theindiantelegraph.com.au/
Established in 2007, The Indian Telegraph is a multi award winning digital media company based in Australia.

A NEW study the Indian Institute of Science (IISc) carried out in collaboration with the Gerry Martin Project (Survey #1418/1419 Rathnapuri, Hunsur, Karnataka) and the Madras Crocodile Bank Trust and Centre for Herpetology has found that commercially available antivenoms in India can be ineffective in treating bites from certain medically important but neglected snakes. According to a release from the IISc, though the bites of these snakes are harmful to humans, the snakes are poorly studied. The study was published in “PLoS Neglected Tropical Diseases”.

“India is the snakebite capital of the world,” said the senior author of the study, Kartik Sunagar of the IISc’s Centre for Ecological Sciences. Each year in India, says the release, about 46,000 people die and 140,000 people are disabled because of snakebites. The only scientifically validated treatment for snakebites is the use of antivenom, for which manufacturing protocols have remained unchanged for over a century. In India, a polyvalent antivenom is produced against the so-called “big four” snakes: the spectacled cobra, the common krait, the Russell’s viper and the saw-scaled viper.

India is home to 270 species of snakes, about 60 of which are considered medically important. But specific antivenoms are not produced against these species; instead, the big four antivenom is routinely used to treat all snakebites.To better understand the consequences of using the polyvalent antivenom to treat all snakebites, the researchers conducted a twofold study.

In the first part, they characterised the venoms of the major neglected snakes—including the Sochurek’s saw-scaled viper, the Sind krait, the banded krait and two populations of monocled cobras, as well as their closest big four relatives (saw-scaled viper, common krait and spectacled cobra)—on the basis of their composition, pharmacological activities and potencies.

The results revealed that the venom compositions of these snakes were significantly different and also differed between geographically separated populations of the same species. “For instance, stark variation was observed in the venoms of two populations of the same monocled cobra species from West Bengal and Arunachal Pradesh. The former was found to be highly neurotoxic (targeting the nervous system) while the latter was rich in cytotoxins (targeting cells and tissues),” Sunagar explained.

In the second part of the study, the researchers evaluated how effective commercially marketed Indian antivenoms were. They found that the antivenoms were highly inefficient in overcoming the effects of the toxins, with one of the antivenoms being completely ineffective against the Arunachal Pradesh monocled cobra in a mouse model. Surprisingly, this widely marketed commercial antivenom even failed to neutralise the venom of the common krait from north India.

The study also found that the venom of the Sind krait from western India is over 40 times more potent than that of the spectacled cobra, making it the most venomous Indian snake. There is, therefore, a pressing need to develop region-specific snakebite therapies for the many neglected species, Sunagar said. The paper provides directions for Indian antivenom manufacturers to improve the pan-India effectiveness of their commercially marketed antivenoms. According to him, the researchers have initiated collaborations with some Indian antivenom manufacturers to produce these regionally effective antivenoms.

Latest article

COVID-19 Melbourne: Victoria information one new case

Victoria has recorded only one new case of COVID-19 and recorded no additional deaths on Saturday.It brings Melbourne’s rolling 14 day common to...

Mosman crash: Man on run after crashing stolen Hyundai in police pursuit

Police are looking for the motive force of a stolen automobile that was totalled in a wild crash following a pursuit by means...

ASX: Worst weekly fall since April

The Australian sharemarket completed the final buying and selling day of the month on a bitter notice, racking up its worst weekly fall...

Robert Graham Thomas appeals homicide conviction

A person jailed for strangling a Brisbane mom to loss of life earlier than stealing her cash claims he suffered a miscarriage of...

Central Coast Council suspended after price range blowout

An NSW council has been suspended after blowing the price range and requiring a $6.2 million bailout from the state authorities. Central Coast...